BBOTVSESYN• 3 Months (Normalized)
BBOT vs ESYN (BridgeBio Oncology Therapeutics Inc. vs EnerSyn Global Inc.)
Showing Closing Date Range from Jul 8 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.5
-61.2%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
ESYN Performance $2.1
-18.29%
EnerSyn Global Inc.
Normalized Baseline0.00%
Alpha Spread Margin ESYN LEADS
-42.91 pts
ESYN outperforming by 42.91 percentage points
BBOTESYN
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT ESYN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(64 dates)
| Date | BBOT Price | BBOT Gain (%) | ESYN Price | ESYN Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 06, 2026 | $3.50 | -61.20% | $2.10 | -18.29% | -42.91% |
| Oct 05, 2026 | $3.60 | -60.09% | $2.12 | -17.51% | -42.58% |
| Oct 02, 2026 | $3.89 | -56.87% | $2.18 | -15.18% | -41.69% |
| Oct 01, 2026 | $- | $2.10 | -18.29% | - | |
| Sep 30, 2026 | $4.10 | -54.55% | $2.28 | -11.28% | -43.27% |
| Sep 29, 2026 | $3.92 | -56.54% | $2.32 | -9.92% | -46.62% |
| Sep 28, 2026 | $3.81 | -57.76% | $2.57 | +0.00% | -57.76% |
| Sep 25, 2026 | $3.95 | -56.21% | $- | - | |
| Sep 24, 2026 | $3.99 | -55.76% | $- | - | |
| Sep 23, 2026 | $4.16 | -53.88% | $- | - | |
| Sep 22, 2026 | $4.66 | -48.34% | $- | - | |
| Sep 21, 2026 | $4.66 | -48.34% | $- | - | |
| Sep 18, 2026 | $4.77 | -47.12% | $- | - | |
| Sep 17, 2026 | $4.89 | -45.79% | $- | - | |
| Sep 16, 2026 | $4.76 | -47.23% | $- | - |
Page 1 of 5